Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01116 |
| Species: | Homo sapiens |
| Position : | chr20:48900221-48901229 |
| Year: | 2019 |
| Title: | Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | hepatocellular carcinoma |
| PMID: | 30659195 |
| MONDO: | MONDO:0007256 |
| Tissue: | liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | Huh-7 |
| CVCL ID: | CVCL_0336 |
| Experiment Type: | Enhancer methylation mapping; endogenous enhancer deletion; enhancer-target and tumorigenic validation; Endogenous enhancer perturbation |
| High Throughput Method: | MBDCap-seq; WGBS; ChIP-seq; RNA-seq; Hi-C; whole-genome sequencing |
| Low Throughput Method: | CRISPR/Cas9 enhancer deletion; luciferase reporter assay; ChIP-qPCR; RT-qPCR; Western blot; bisulfite pyrosequencing; CRISPR-Cas9 endogenous deletion/editing |
| Target gene : | CEBPB |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_02876 | chr20:48400000-49200000 | breast | malignant cell | breast cancer |
| E_02877 | chr20:48400000-49200000 | breast | malignant cell | breast cancer |
| E_01098 | chr20:48900221-48901229 | liver | hepatoblast | hepatocellular carcinoma |
| E_01105 | chr20:48900221-48901229 | liver | NA | hepatocellular carcinoma |
| E_01106 | chr20:48900221-48901229 | liver | NA | hepatocellular carcinoma |
| E_01107 | chr20:48900221-48901229 | liver | malignant cell | hepatocellular carcinoma |
| E_01108 | chr20:48900221-48901229 | liver | hepatocyte | hepatocellular carcinoma |
| E_01115 | chr20:48900221-48901229 | liver | NA | hepatocellular carcinoma |
| E_01143 | chr20:48900221-48901229 | uterine cervix | NA | hepatocellular carcinoma |
| E_01145 | chr20:48900221-48901229 | liver | NA | hepatocellular carcinoma |